Prenatal diagnosis of X-linked chronic granulomatous disease using restriction fragment length polymorphism analysis. 1987

M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
Department of Medical Genetics, University of Helsinki, Finland.

Prenatal diagnosis of X-linked chronic granulomatous disease (CGD) was performed with restriction fragment length polymorphism (RFLP) analysis using probes flanking the gene. The male fetus and an affected male displayed the same haplotype for RFLPs belonging to six linked loci extending from DXS164 to DXS7, which encompass the CGD locus, and for which the mother was heterozygous. Diagnosis of an affected fetus was confirmed after termination of the pregnancy by the study of fetal granulocytes using the nitroblue tetrazolium reduction test. In informative families prenatal diagnosis of CGD can be made earlier by RFLP analysis than by fetal blood sampling.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D009580 Nitroblue Tetrazolium Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease. Nitro-BT,Nitrotetrazolium Blue,Tetrazolium Nitroblue,Blue, Nitrotetrazolium,Nitroblue, Tetrazolium,Tetrazolium, Nitroblue
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004303 Dosage Compensation, Genetic Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female. Dosage Compensation (Genetics),Gene Dosage Compensation,Hypertranscription, X-Chromosome,X-Chromosome Hypertranscription,Compensation, Dosage (Genetics),Compensation, Gene Dosage,Compensation, Genetic Dosage,Dosage Compensation, Gene,Gene Dosage Compensations,Genetic Dosage Compensation,Genetic Dosage Compensations,Hypertranscription, X Chromosome,X Chromosome Hypertranscription

Related Publications

M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
January 1986, Prenatal diagnosis,
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
December 1993, Blood,
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
December 1986, Journal of medical genetics,
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
April 2011, Anales de pediatria (Barcelona, Spain : 2003),
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
May 2001, Current protocols in human genetics,
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
November 2012, Scandinavian journal of immunology,
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
April 1991, BioTechniques,
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
February 1986, The Journal of clinical investigation,
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
January 2002, Methods in molecular biology (Clifton, N.J.),
M Lindlöf, and J Kere, and M Ristola, and H Repo, and M Leirisalo-Repo, and H von Koskull, and P Ammälä, and A de la Chapelle
January 1990, Experimental and clinical immunogenetics,
Copied contents to your clipboard!